About Event
Mengenai Acara
关于活动
Propelling the Development of Cell Therapy Drugs in the Asia-Pacific Region
This year’s jampacked agenda brings you an end-to-end coverage of all things cell therapy, from leading biotechs, academics, venture capitals and regulatory bodies! Attend with your team for insightful discussions with industry leaders as they discuss the dynamic and rapidly evolving cell therapy landscape, and learn to make informed investment decisions and align financial objectives for the advancement of medical science across the APAC region.
Who's Attending?
Key Reasons To Attend This Year:
1
Network with industry leaders from across the APAC region, with key representatives from Vietnam, China, Singapore, Taiwan, India and Australia presenting end-to-end content from preclinical to commercialization to help you gain competitive advantage and optimize your drug development process
2
Gain key investment factors from venture capitalists to hear first hand how current trends can benefit your bargaining power when attracting investors to invest in your cell therapy product
3
Achieve clear visibility across leading cell therapy modalities: CAR-T, TCR-T, Gamma Delta T and NK cells, exploring their distinct mechanisms of action, therapeutic potential, and current clinical applications
4
Improve your understanding of regulatory insights and commercial expertise to effectively navigate the complex landscape of cell therapy submissions, by learning from industry veterans who have successfully commercialized cell therapy products, ensuring both speed and success in bringing your product to market
5
Optimize your manufacturing and CMC strategies through multiple commercial case studies describing from start to finish how to harmonize GMP set ups, apply phase appropriate capacity planning, minimize the impact of donor variability and how to keep in line with regulatory requirements
